UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

Annals of oncology, 2017-11, Vol.28 (suppl_8), p.viii8-viii12

2017

Volltextzugriff (PDF)

Combination photoimmunotherapy and cisplatin : Effects on human ovarian cancer ex vivo

JNCI : Journal of the National Cancer Institute, 1999-09, Vol.91 (18), p.1557-1563

1999

Volltextzugriff (PDF)

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Annals of oncology, 2018-10, Vol.29, p.viii404-viii405

2018

Volltextzugriff (PDF)

Epithelial ovarian carcinoma in the reproductive age group

Cancer, 1999-06, Vol.85 (12), p.2623-2629

1999

Volltextzugriff (PDF)

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Cancer, 2000-10, Vol.89 (7), p.1532-1540

2000

Volltextzugriff (PDF)

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer

British journal of cancer, 1997, Vol.75 (6), p.837-844

1997

Volltextzugriff (PDF)

Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

European journal of cancer (1990), 2022-10, Vol.174, p.S67-S67

2022

Volltextzugriff (PDF)

Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

European journal of cancer (1990), 2022-10, Vol.174, p.S31-S32

2022

Volltextzugriff (PDF)

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer

Cancer research (Chicago, Ill.), 2004, Vol.64 (1), p.202-208

2004

Volltextzugriff (PDF)

A Phase I Study of Continuous Infusion Doxorubicin and Paclitaxel Chemotherapy with Granulocyte Colony-Stimulating Factor for Relapsed Epithelial Ovarian Cancer

Clinical cancer research, 1999-06, Vol.5 (6), p.1299-1305

1999

Volltextzugriff (PDF)

1139PDNovel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

Annals of oncology, 2017-11, Vol.28 Suppl 8, p.viii8

2017

Volltextzugriff (PDF)

LBA60Randomized phase II (RP2) study of ATR inhibitor M6620 in combination with gemcitabine versus gemcitabine alone in platinum-resistant high grade serous ovarian cancer (HGSOC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel

International journal of gynecological cancer, 2006-01, Vol.16 (Suppl 1), p.267-272

2006

Volltextzugriff (PDF)

A phase 1b study of the nanoparticle-drug conjugate (NDC) CRLX101 in combination with weekly paclitaxel in patients (pts) with platinum-resistant ovarian cancer (OC)

Annals of oncology, 2016-10, Vol.27, p.vi298-vi298

2016

Volltextzugriff (PDF)

Hypersensitivity reactions to cetuximab

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13054-e13054

2011

Volltextzugriff (PDF)

Fallopian Tube Carcinoma

Surgical oncology clinics of North America, 1998-04, Vol.7 (2), p.363-373

1998

Volltextzugriff (PDF)

A gene expression algorithm for the prediction of platinum sensitivity in ovarian cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5021-5021

2010

Volltextzugriff (PDF)

Advanced stage serous papillary ovarian cancer: Impact of histological grade in clinical outcomes

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16579-16579

2008

Volltextzugriff (PDF)

Phase II multi-institutional study of docetaxel plus aflibercept (AVE0005, NSC# 724770) in patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5017-5017

2011

Volltextzugriff (PDF)

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5066-5066

2011

Volltextzugriff (PDF)

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5047-5047

2011

Volltextzugriff (PDF)

Comparison of the quality of life of early and advanced stage ovarian cancer survivors

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5528-5528

2008

Volltextzugriff (PDF)

Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5523-5523

2008

Volltextzugriff (PDF)

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

International journal of gynecological cancer, 2000-01, Vol.10 (1), p.33-41

2000

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

ThemaObstetrics & Gynecology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(103)
Buchkapitel
(6)

Sprache

Englisch
(109)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

Combination photoimmunotherapy and cisplatin : Effects on human ovarian cancer ex vivo

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Epithelial ovarian carcinoma in the reproductive age group

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer

Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer

A Phase I Study of Continuous Infusion Doxorubicin and Paclitaxel Chemotherapy with Granulocyte Colony-Stimulating Factor for Relapsed Epithelial Ovarian Cancer

1139PDNovel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

LBA60Randomized phase II (RP2) study of ATR inhibitor M6620 in combination with gemcitabine versus gemcitabine alone in platinum-resistant high grade serous ovarian cancer (HGSOC)

Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel

A phase 1b study of the nanoparticle-drug conjugate (NDC) CRLX101 in combination with weekly paclitaxel in patients (pts) with platinum-resistant ovarian cancer (OC)

Hypersensitivity reactions to cetuximab

Fallopian Tube Carcinoma

A gene expression algorithm for the prediction of platinum sensitivity in ovarian cancer

Advanced stage serous papillary ovarian cancer: Impact of histological grade in clinical outcomes

Phase II multi-institutional study of docetaxel plus aflibercept (AVE0005, NSC# 724770) in patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD)

Comparison of the quality of life of early and advanced stage ovarian cancer survivors

Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

Aktive Filter

Suchergebnisse filtern